IL10 and infection: Again, B. dorei-treatment significantly reduced the levels of IL-1β, IL-6, TNF-α, IL-10, MCP-1 and IP-10 in lung compared with PBS-treated infection mice at day 7 p.i., to a comparable degree relative to the oseltamivi treatment (Figures 5A–F).